The LymeX Diagnostics Prize will call on scientific, technical, and clinical experts to submit innovative detection methods that will advance Lyme disease diagnostics. The ultimate goal of the competition is to develop diagnostics, which would be submitted to the Food and Drug Administration for review, that detect active Lyme disease infections in people.
A $10+ million competition to accelerate the development of Lyme disease diagnostics
Sign up for competition updates
About LymeX
The Lyme Innovation Accelerator (LymeX), a partnership between the U.S. Department of Health and Human Services (HHS) and the Steven & Alexandra Cohen Foundation, is the world’s largest public-private partnership for Lyme disease. LymeX, as a component of a larger moonshot, is identifying, developing, and implementing advancements in Lyme disease care — including next-generation diagnostics. Additional information about the competition is available at Challenge.gov.